The Intriguing Regulators of Muscle Mass in Sarcopenia and Muscular Dystrophy

Recent advances in our understanding of the biology of muscle have led to new interest in the pharmacological treatment of muscle wasting. Loss of muscle mass and increased intramuscular fibrosis occur in both sarcopenia and muscular dystrophy. Several regulators (mammalian target of rapamycin, seru...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakuma, Kunihiro, Aoi, Wataru, Yamaguchi, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148637/
https://www.ncbi.nlm.nih.gov/pubmed/25221510
http://dx.doi.org/10.3389/fnagi.2014.00230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148637/
https://www.ncbi.nlm.nih.gov/pubmed/25221510
http://dx.doi.org/10.3389/fnagi.2014.00230

Ejemplares similares